|
1
|
Development of a highly efficient expression cDNA cloning system: application to oncogene isolation.
|
Proc Natl Acad Sci U S A
|
1991
|
2.48
|
|
2
|
Autocrine interaction between TGF alpha and the EGF-receptor: quantitative requirements for induction of the malignant phenotype.
|
Oncogene
|
1989
|
1.57
|
|
3
|
Occupation and the carpal tunnel syndrome.
|
Med J Aust
|
1994
|
1.39
|
|
4
|
The erbB-2 mitogenic signaling pathway: tyrosine phosphorylation of phospholipase C-gamma and GTPase-activating protein does not correlate with erbB-2 mitogenic potency.
|
Mol Cell Biol
|
1991
|
1.36
|
|
5
|
Autocrine mechanism for v-sis transformation requires cell surface localization of internally activated growth factor receptors.
|
Proc Natl Acad Sci U S A
|
1989
|
1.29
|
|
6
|
Angiotensin II induces delayed mitogenesis and cellular proliferation in rat aortic smooth muscle cells. Correlation with the expression of specific endogenous growth factors and reversal by suramin.
|
J Clin Invest
|
1994
|
1.08
|
|
7
|
Synthesis of thiophene-2-carboxamidines containing 2-aminothiazoles and their biological evaluation as urokinase inhibitors.
|
Bioorg Med Chem Lett
|
2001
|
1.03
|
|
8
|
Endothelin-1 and angiotensin-II stimulate delayed mitogenesis in cultured rat aortic smooth muscle cells: evidence for common signaling mechanisms.
|
Mol Endocrinol
|
1994
|
1.02
|
|
9
|
Angiotensin II stimulation of rapid paxillin tyrosine phosphorylation correlates with the formation of focal adhesions in rat aortic smooth muscle cells.
|
J Cell Sci
|
1995
|
0.99
|
|
10
|
Epidermal growth factor activates phosphoinositide turnover and protein kinase C in BALB/MK keratinocytes.
|
Mol Endocrinol
|
1988
|
0.97
|
|
11
|
Epiregulin is a potent vascular smooth muscle cell-derived mitogen induced by angiotensin II, endothelin-1, and thrombin.
|
Proc Natl Acad Sci U S A
|
1999
|
0.96
|
|
12
|
Activation of the colony-stimulating factor 1 receptor leads to the rapid tyrosine phosphorylation of GTPase-activating protein and activation of cellular p21ras.
|
Oncogene
|
1992
|
0.93
|
|
13
|
Characterization of platelet-derived growth factor and platelet-derived growth factor receptor expression in asbestos-induced rat mesothelioma.
|
Cancer Res
|
1992
|
0.93
|
|
14
|
Overexpression of phospholipase C-gamma in NIH 3T3 fibroblasts results in increased phosphatidylinositol hydrolysis in response to platelet-derived growth factor and basic fibroblast growth factor.
|
Mol Cell Biol
|
1990
|
0.90
|
|
15
|
The calcium signal for Balb/MK keratinocyte terminal differentiation induces sustained alterations in phosphoinositide metabolism without detectable protein kinase C activation.
|
J Biol Chem
|
1989
|
0.90
|
|
16
|
Demonstration of an activated platelet-derived growth factor autocrine pathway and its role in human tumor cell proliferation in vitro.
|
Oncogene
|
1992
|
0.90
|
|
17
|
Stimulation of activin A expression in rat aortic smooth muscle cells by thrombin and angiotensin II correlates with neointimal formation in vivo.
|
J Clin Invest
|
1997
|
0.86
|
|
18
|
Specific alterations in keratin biosynthesis in mouse epidermis in vivo and in explant culture following a single exposure to the tumor promoter 12-O-tetradecanoylphorbol-13-acetate.
|
Cancer Res
|
1987
|
0.84
|
|
19
|
Activin A and TGF-beta stimulate phosphorylation of focal adhesion proteins and cytoskeletal reorganization in rat aortic smooth muscle cells.
|
Exp Cell Res
|
1999
|
0.83
|
|
20
|
Orally active endothelin receptor antagonist BMS-182874 suppresses neointimal development in balloon-injured rat carotid arteries.
|
J Cardiovasc Pharmacol
|
1995
|
0.80
|
|
21
|
Uneven distribution of protein kinase C-alpha and -beta isozymes in human sarcomas and carcinomas.
|
J Cell Physiol
|
1994
|
0.80
|
|
22
|
Expression of protein kinase CI in NIH 3T3 cells increases its growth response to specific activators.
|
FEBS Lett
|
1990
|
0.78
|
|
23
|
Effects of thrombin receptor activating peptide on phosphoinositide hydrolysis and protein kinase C activation in cultured rat aortic smooth muscle cells: evidence for "tethered-ligand" activation of smooth muscle cell thrombin receptors.
|
Biochem Pharmacol
|
1993
|
0.78
|
|
24
|
Structure-based design, synthesis and SAR of a novel series of thiopheneamidine urokinase plasminogen activator inhibitors.
|
Bioorg Med Chem Lett
|
2001
|
0.76
|
|
25
|
Alterations in the expression of specific epidermal keratin markers in the hairless mouse by the topical application of the tumor promoters 2,3,7,8-tetrachlorodibenzo-p-dioxin and the phorbol ester 12-O-tetradecanoylphorbol-13-acetate.
|
Carcinogenesis
|
1987
|
0.75
|
|
26
|
Pharmacodynamics and pharmacokinetics of the novel thrombopoietin mimetic peptide RWJ-800088 in humans.
|
Clin Pharmacol Ther
|
2008
|
0.75
|
|
27
|
Extradural haematoma: trends in outcome over 35 years.
|
Br J Neurosurg
|
1993
|
0.75
|
|
28
|
Management of cranial deformity following ventricular shunting.
|
Childs Nerv Syst
|
2009
|
0.75
|
|
29
|
Alterations in expression of p56lck during myeloid differentiation of LSTRA cells.
|
Cell Growth Differ
|
1994
|
0.75
|